Purchases and Sales Made in Q1 2022 in Rhythm Pharmaceuticals, Inc. (RYTM)
This table provides information about the institutional ownership of Rhythm Pharmaceuticals, Inc. (RYTM) during Q1 2022. The information is specifically focused on institutions that hold shares of RHYTHM PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-103K- 99.52% |
$632K - $1.26M
|
500
$28.9K
|
|
|
May 13, 2022
Q1 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-112KClosed |
$684K - $1.37M
|
0
$0
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-175K- 40.69% |
$1.07M - $2.15M
|
255K
$14.8M
|
|
|
May 16, 2022
Q1 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-183K- 5.84% |
$1.12M - $2.24M
|
2.95M
$171M
|
|
|
May 16, 2022
Q1 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-660K- 88.5% |
$4.05M - $8.08M
|
85.8K
$4.96M
|
|
|
May 16, 2022
Q1 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.12M- 57.99% |
$6.87M - $13.7M
|
811K
$46.9M
|
|
|
May 16, 2022
Q1 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-1.58M- 84.42% |
$9.66M - $19.3M
|
291K
$16.8M
|